SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 430.14 |
Enterprise Value ($M) | 326.71 |
Book Value ($M) | 74.94 |
Book Value / Share | 0.40 |
Price / Book | 5.74 |
NCAV ($M) | 52.07 |
NCAV / Share | 0.28 |
Price / NCAV | 8.26 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.82 |
Return on Assets (ROA) | -1.10 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.08 |
Current Ratio | 4.08 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 149.87 |
Assets | 172.73 |
Liabilities | 97.79 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 15.45 |
Operating Income | -71.37 |
Net Income | -111.57 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -73.02 |
Cash from Investing | -7.35 |
Cash from Financing | 136.39 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Rtw Investments, Lp | 9.80 | ||
13G/A | Venrock Healthcare Capital Partners III, L.P. | 5.60 | -27.91 | |
13G/A | Ra Capital Management, L.p. | 9.99 | -0.11 | |
13G/A | Fmr Llc | 12.00 | -19.78 | |
13G/A | TCG Crossover GP I, LLC | 1.60 | -73.78 | |
13D/A | Manning Paul B | 12.60 | 235.86 | |
13D/A | Astellas Pharma Inc. | 3.89 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
181,234 | 842,034 | 21.52 | |
351,212 | 1,560,849 | 22.50 | |
183,885 | 238,928 | 76.96 | |
364,355 | 487,854 | 74.69 | |
359,550 | 439,666 | 81.78 | |
(click for more detail) |
Similar Companies | |
---|---|
TLRY – Tilray Brands, Inc. | TNYA – Tenaya Therapeutics, Inc. |
TRML – Tourmaline Bio, Inc. | TSVT – 2seventy bio, Inc. |
TWST – Twist Bioscience Corporation |
Financial data and stock pages provided by
Fintel.io